Sight Sciences, Inc.
Cash Flow Statement
| Line Item | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 |
|---|---|---|---|---|---|---|
| Operating Activities | ||||||
| Net Income | $-38.4M | $-51.5M | $-55.5M | $-86.2M | $-63.0M | $-34.7M |
| Depreciation & Amortization | $487.0K | $712.0K | $614.0K | — | — | — |
| Depreciation | $300.0K | $500.0K | $600.0K | $710.0K | $632.0K | $554.0K |
| Amortization | — | — | — | — | — | — |
| Stock-Based Compensation | $13.1M | $17.1M | $14.6M | $13.0M | $5.1M | $497.0K |
| Net Cash from Operating Activities | $-29.7M | $-22.4M | $-47.2M | $-76.0M | $-52.5M | $-32.2M |
| Investing Activities | ||||||
| Capital Expenditures | $224.0K | $385.0K | $791.0K | $970.0K | $813.0K | $953.0K |
| Business Acquisitions | — | — | — | — | — | — |
| Net Cash from Investing Activities | $-224.0K | $-385.0K | $-791.0K | $-970.0K | $-813.0K | $-953.0K |
| Financing Activities | ||||||
| Dividends Paid | — | — | — | — | — | — |
| Stock Repurchases | — | — | — | — | — | — |
| Net Cash from Financing Activities | $1.8M | $5.0M | $1.1M | $1.2M | $252.5M | $73.4M |
| Net Change in Cash | $-28.1M | $-17.8M | $-46.9M | $-75.7M | $199.2M | $40.3M |
| Free Cash Flow | $-29.9M | $-22.7M | $-48.0M | $-76.9M | $-53.4M | $-33.1M |